Autopsy report · NCT04159935

Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease

“Cancelled due to COVID-19”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 months before it stopped.
• 28 participants enrolled.
• Results were posted on the registry 3 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Waterloo

Sponsor type

University, hospital or other

Conditions

Dry Eye

Interventions

iLux® system

Participants

28

Sites

1

Countries

Canada

Trials that died the same way

• Effect of Artificial Tears on Biometry
  “Stopped due to COVID-19.” (77% match in meaning)
• The Norwegian Prednisolone in Early Psychosis Study
  “Stopped because of COVID 19 pandemic” (75% match in meaning)
• Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA
  “Terminated due to COVID-19” (73% match in meaning)
• Spinal Anesthetic for Hip and Knee Replacement Surgery - Intrathecal Morphine or Hydromorphone
  “Delayed due to COVID and no longer relevant” (69% match in meaning)
• RAman For Thyroid cancER
  “Covid19 halted study” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.